Shenfu Injection for Septic Shock Blood Flow Problems
Treatments studied
Part of Infections clinical trials.
This study tests whether a traditional Chinese medicine injection (Shenfu) can improve blood flow and organ function in patients with septic shock—a life-threatening infection where the body's blood pressure drops dangerously low despite fluids. Researchers want to see if this treatment helps the heart pump blood more effectively to vital organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have septic shock (a severe blood infection causing dangerously low blood pressure) that was diagnosed within the last 24 hours and required ICU admission
- You are at least 18 years old
- You are currently on a strong blood-pressure medication (norepinephrine) through an IV to keep your blood pressure safe
- You are on a breathing machine (ventilator) in the ICU with sedation and pain medication
- You have special monitoring tubes in place: one in an artery and one in a large vein, with advanced equipment measuring your heart's pumping ability
- You do not have a primary heart problem (your heart is pumping adequately after treatment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether Shenfu injection can improve the flexibility of blood vessels in people with severe infections (sepsis or septic shock). It may help understand how to better support the heart and circulation during critical illness.
This trial tests whether Shenfu injection can help prevent heart muscle damage in people with septic shock. If you have septic shock, you may be able to join this study to see if this treatment helps protect your heart.
This study tests whether a medicine called anisodamine can improve blood flow in tiny vessels (microcirculation) under your tongue and help stabilize blood pressure in patients with septic shock. It may offer a new way to support recovery in the ICU.
This study tests whether adding a sedative called dexmedetomidine, along with your current care, can improve blood flow in small blood vessels under the tongue for people with septic shock in the ICU.
This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.